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The 1 I-kDa E 1 b protein in Ad 12-transformed rat cells and in Ad 12-infected human cells binds lipid strong- 
ly. The lipid is not removed by boiling in the presence of SDS or by extraction with methanol/chloroform. 
It is, however, dissociated from the protein by treatment with methanolic KOH suggesting that attachment 
is through an ester linkage. The acylated 18-kDa protein is detected only in the membrane fraction. Label- 
ling cell surface proteins on Ad 12-transformed cells with [*ZSI]iodosulphanilic acid shows that some of the 
Ad 12 18-kDa El b protein is present on the outside of the cell. It is concluded that this protein is responsible 
for cell surface T-antigen activity. 
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1. INTRODUCTION 
For the morphological changes associated with 
transformation to occur the transforming proteins 
of tumour viruses must exert considerable in- 
fluence on different organelles in the host cell. It 
seems likely that these changes are achieved 
through a series of interactions of the viral proteins 
with specific sites in the cell. For example, a pro- 
portion of the transforming protein of Rous sar- 
coma virus (RSV) (pp 60 src) [1,2] and most of 
middle-T antigen of polyoma virus are primarily 
associated with plasma membranes [3], whereas si- 
mian virus 40 (SV40) large-T is mainly present in 
the nucleus [4]. It has recently become apparent 
that a number of the viral transforming proteins 
which are present in the membrane of the host cell 
have been specially modified by the attachment of 
lipid at specific points in the amino acid sequence 
[5&l. 
The region of the adenovirus 12 (Ad 12) 
chromosome whose expression is sufficient to in- 
duce transformation, early region 1, consists of 
two transcriptional units: Ela and Elb [7,8]. The 
former codes for a family of proteins of molecular 
mass of about 41 kDa, as determined by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE), 
whereas the latter codes for two proteins of 
molecular masses 19 and 60 kDa [9, lo] (equivalent 
to proteins of 18 and 52 kDa, respectively, in our 
hands). Although under certain circumstances rat 
cells expressing only the Ela proteins may exhibit 
a limited transformed phenotype, transformation 
is accomplished much more efficiently if the Elb 
proteins are present as well [l 1,121. In the light of 
the results which showed that lipid is bound to 
various transforming proteins [5,6] we have in- 
vestigated whether any of the tumour antigens of 
Ad 12 are subject to a similar post-translational 
modification particularly as at least some of the 
18-kDa protein has been shown to be membrane- 
bound [13]. 
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2. MATERIALS AND METHODS 
A number of different cell lines were used in 
these experiments: Hooded Lister baby rat kidney 
cells (HLBRK) and Hooded Lister rat embryo 
brain (HLREB) cells each are transformed with the 
EcoRIC or f;lindIIIG fragments of Ad 12 DNA 
[12] (submitted), transformed rat liver cells con- 
taming the left-hand 16% of the Ad 12 genomc 
(Ad 12/C3/100-1) [14], and human embryo kidney 
cells transformed with the EcoRIC fragment of Ad 
12 DNA (Ad 12 HEK2) 1151. 
Transformed cells were labelled with [9,10- 
3H(n)]palmitic acid, as described by Schmidt and 
Schlesinger [16] and Sefton et al. [5], for 6 h at 
37°C (3 mCi/lO’ cells); [9,10-3H(n)]palmitic acid 
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was also added to dishes of Ad 12-infected human 
embryo kidney cells (HEKs) 24 h post-infection 
and the cells harvested 30 h post-infection. Ad 
1Ztransformed cells were also labelled with 
[3SS]methionine for 2 h in methionine-free 
medium. After radioactive labelling the cells were 
scraped off the dishes and dissolved in im- 
munoprecipitation lysis buffer [ 171. Immuno- 
precipitation was by the procedure of Paraskeva et 
al. [17] using specific Ad 12 rat tumour bearer sera 
(reactive only to Ela 41- and Elb 18- and 52-kDa 
proteins). Immunoprecipitates were dissolved in 
9 M urea, 50 mM Tris-HCl (pH 7.5), 1% ,0- 
mercaptoethanol, 1% SDS (25 ~1) and run on 13% 
polyacrylamide gels in the presence of 0.1% SDS 
and 0.1 M Tris, 0.1 M Bicine (pH 8.3). Radio- 
labelled proteins were detected by fluorography. In 
the case of [35S]methionine-labelled proteins the 
films were exposed to the dried gels for 5 days, but 
for detection of ‘H-labelled proteins exposure was 
normal for approx. 8 weeks. Autoradiographs 
were scanned using an Isco gel scanner. 
Membranes were prepared from Ad 12 Hin- 
dIIIG HLREB cells (5 x 10 cm dishes) by 
homogenisation in 10% sucrose, 0.5 mM EDTA, 
pH 7.2 (5 ml) using a Dounce tight-fitting 
homogeniser (50 strokes). Nuclei were removed by 
centrifugation at 1000 x g for 5 min. The superna- 
tant from this step was centrifuged at 100000 x g 
for 1.5 h and the precipitate taken as a crude mem- 
brane preparation. 
To examine whether any of the Ad 12 El pro- 
teins could be labelled on the cell surfaces, rat and 
human cells (approx. 1 g of each) transformed 
with the EcoC fragment of Ad 12 DNA (Ad 12 
EcoC HLBRK and Ad 12 HEK 2, respectively) 
were washed with saline and suspended in PBS 
(2.5 ml). Surface proteins were labelled with 
diazotised [‘251]iodosulphanilic a id (0.2 mCi) for 
20 min at 5°C using the method of Schlager [18]. 
After extensive washing with PBS containing 1% 
BSA most of the cells were homogenised in 10% 
sucrose and nuclear and membrane fractions 
separated by differential centrifugation. A second 
experiment was performed using similar amounts 
of cells in which radiolabelling occurred after 
disruption and subcellular fractionation. Aliquots 
(50~1) from each fraction were immunopre- 
cipitated and the adenovirus proteins electro- 
phoresed on polyacrylamide gels in the presence of 
SDS. Autoradiographs were scanned using an Isco 
gel scanner. 
3. RESULTS AND DISCUSSION 
3.1. Labeling of Ad 12 Elb 18-kDa protein with 
tH]palmitic acid 
It can be seen from fig.1, scans a-d that, after 
- 
Fig.1. Binding of [3H]palmitate to Ad 12 Elb 18-kDa protein. Ad la-transformed rat cells were grown on IO-cm Petri 
dishes in DME medium supplemented with 10% foetal calf serum. [9,10--‘H(n)]Palmitic acid (23.5 Ci/mM, New 
England Nuclear), which had been dried in a stream of N2 and redissolved in DMSO (1 mCi/l6gI), was added 
(3.2 mCi/dish) and after 6 h the cells were washed with ice-cold saline, harvested with a rubber policeman and 
solubilized in immunoprecipitation lysis buffer [ 171. Other dishes were also labelled with [35S]methionine (800 Ci/mM, 
Amersham International) in methionine-free medium (200 &i/dish); I3 % polyacrylamide gels were run in the presence 
of 0.1% SDS, 0.1 M Tris, 0.1 M Bicine (pH 8.3). Autoradiographs were subjected to densitometric scanning and the 
Ad 12 tumour antigens are indicated by arrows. 0 indicates the origin. No proteins were immunoprecipitated with non- 
immune rat serum, and no proteins were immunoprecipitated from mock-infected HEKs. Scans a-d, 
immunoprecipitation of 3H-labelled (a, c, d) and 3SS-labelled (b) cells. Scans a, b, Ad 12-transformed rat liver cells (Ad 
12/C3/100-1 cells); scan c, Ad 12-infected (50 pfu/cell) HEKs; scan d, Ad 12 HindIIIG HLREB-transformed cells. 
Scans e-h, effect of methanolic KOH on ‘H- and 3’S-labelled Ad 12 proteins. Ad 12-transformed rat liver cells (Ad 
12/C3/100-1) were labelled with [3H]palmitate (e, f) or [35S]methionine (g, h) and immunoprecipitated with rat tumour 
bearer serum. Scans f and h show the results obtained after incubation of the immunoprecipitates in 0.1 M KOH for 
20 min at 23°C. The immunoprecipitates shown in scans e and g were untreated. Scans i and j, effects of trypsin on 
‘H-labelled Ad 12 18-kDa Elb protein. Membranes prepared from Ad 12 HindIIIG HLREB cells (see text) were treated 
with trypsin (20 pg for1 h at 30°C) before solubilisation and immunoprecipitation. Scan i, untreated; scan j, treated 
with trypsin. Scans k and I, effect of tunicamycin on the incorporation of [-‘H]palmitate into Ad 12-infected HEKs. 
Tunicamycin (2pg/ml) was added to Ad 12-infected HEKs at the same time as the [3H]paImitate. Scan k, untreated 
cells; scan I, treated with tunicamycin. 
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labelling with [3H]palmitic acid, radioactivity was 
incorporated into the Ad 12 IS-kDa Elb protein in 
both Ad IZtransformed rat cells and Ad 
12-infected human embryo kidney cells. A number 
of different rat cell lines were used in this series of 
experiments and in all cases the 18 kDa Elb pro- 
tein was acylated. Similar results were obtained for 
baby rat kidney cells and rat embryo brain cells 
transformed with the EC& and HifldIIIG 
fragments of Ad 12 DNA and rat liver epithelial 
cells (Ad 12/C3/100-1 cells). There seems little 
doubt that the lipid moiety was covalently bound 
to the Ad 12 18 kDa protein since boiling for 5 min 
in I% SDS or repeated extraction of the im- 
munoprecipitates with a mixture of chloroform 
and methanol (2: 1, v/v, 1 ml) failed to remove 
any of the radiolabel although the latter procedure 
did reduce the radioactivity visible at the bottom of 
the gel which was probably due to unbound lipid, 
non-specifically absorbed either onto the proteins 
or onto the staphylococcus aureus used for 
immunoprecipitation. 
3.3, Subcellular distribution of [3H]palmitate- 
Iabelled Ad 12 EIb lb-kDa protein 
A crude membrane preparation was made from 
Ad 12 HindIIIG HLREB cells as described in sec- 
tion 2. Immunoprecipitation confirmed that ap- 
preciable amounts of the acylated Ad 12 1%kDa 
Elb protein were present in this fraction but not in 
the cytosol (not shown). If the membranes were 
treated with trypsin (20 pg for 1 h at 30°C in 0.1 M 
NHdHCO3, pH 7.9) before immunoprecipitation, 
no radiolabelled 1%.kDa protein could be detected 
(fig.1, scan j). It is tentatively suggested therefore 
that part of the protein protrudes out of the mem- 
brane, either on the inside or outside, and when 
this is digested by the protease the radiolabelled 
residue(s) is (are) lost. Alternatively it is possible 
that a relatively large proportion of viral protein is 
not incorporated in the membrane and is therefore 
sensitive to proteolysis in which case im- 
munoprecipitation would not necessarily result in 
the purification of the surviving acylated peptide 
due to loss of the antigenic site. 
3.2. Treatment of PH]palmitate labelled Ad 12 3.4. Effect of tunicamycin on [3H]paimitate 
Elb 18”kDa protein with methanolic KOH 
Schmidt et al. 1191 originally showed that la- 
[abelling 
belled lipid could be removed from Sindbis virus 
glycoproteins by treatment with methanolic KOH. 
Therefore, immunoprecipitates from Ad 12”trans- 
formed cells labelled with [3H]palmitate were in- 
cubated in 0.1 M KOH in methanol at 23°C for 
20 min and then washed with chloroform/metha- 
nol before SDS-PAGE (fig. 1, scans e-h). This 
resulted in the removal of 3H radiolabel from the 
1%kDa protein (scan f) although no difference 
could be seen in samples labelled with [35S]methio- 
nine after KOH treatment (scans g,h). It is there- 
fore likely that the lipid is attached to a hydroxyl 
residue (e.g., serine, threonine or tyrosine) on the 
viral protein through an ester linkage as appears to 
be the case for Sindbis virus glycoprotein [ 191 and 
Harvey Sarcoma virus p21 151. Sefton et al. [5] 
found, however, that the lipid bound to pp60 from 
RSV was not labile under these conditions and they 
concluded that in that case the lipid-protein 
linkage was possibly through an amide bond. 
Whether such differences in lipid binding are in- 
dicative of a different distribution of viral proteins 
in the membrane (e.g., whether it is located on one 
side only or penetrates right through) is not yet 
clear. 
232 
Many of the viral structural proteins which have 
been shown to be acylated are glycoproteins 
(review [20]). However, it is apparent from label- 
ling experiments using [3H]glucosamine added to 
Ad 12-transformed rat cells that neither the Ad 12 
1%kDa Elb protein nor the 41- or 52-kDa El pro- 
teins are glycosylated (not shown). This result is in 
agreement with the findings of Persson et al. 1211 
who could not detect any giycosylation of the Ad 
2 15-kDa membrane protein (equivalent o the Ad 
12 1%kDa). 
Tunicamycin is known to be a potent inhibitor 
of protein glycosylation, but has also been shown 
to inhibit the acylation of the G glycoprotein of a 
ts mutant of vesicular stomatitis virus under cer- 
tain conditions [ 161. We have found, however, that 
the addition of tunicamycin (2pg/ml) to Ad 
1Ztransformed rat cells or to Ad 1Zinfected 
HE& at the same time as the addition of 
~3H]palmitate, did not abolish binding of the lipid 
to the 18-kDa protein although the radioactivity 
was somewhat reduced in the infected cells (fig.1, 
scans k and 1). Whether this indicates a different 
pathway for acylation in the VSV G protein at the 
non-permissive temperature and the Ad 12 1%kDa 
Volume 181. number 2 FEBS LETTERS February 1985 
protein is not clear at present although in both 
cases the lipid is probably attached to the protein 
through an ester linkage (i.e., it is labile in 
methanolic KOH). It seems probable however that 
in the case of VW G protein, acylation cannot be 
considered separately from glycosylation and the 
b 
inhibition of the latter process may affect the 
former. 
It can be seen that when cells infected with Ad 
12 were labelled with [3H]palmitate a minor 
radioactive band of about 15 kDa could be 
detected (fig.1, lanes c, k and 1). No comparable 
d 
Fig.2. Surface labelling of Ad 12 HEK 2 cells with [‘251]iodosulphanilic acid. Ad 12 HEK2 cells (1 g) were suspended 
in 2.5 ml PBS and labelled with [‘251]iodosulphanilic a id. After washing the cells were homogenised in 5 ml of buffered 
10% sucrose and fractionated into nuclear, membrane and cytosolic fractions by differential centrifugation. The nuclear 
and membrane fractions were resuspended in the immunoprecipitation extraction buffer (0.5 ml) used by Paraskeva et 
al. [17]. The cytosolic fraction was diluted 1: 1 with the same buffer. A similar sample of cells was fractionated in the 
same way and then subcellular fractions were labelled with [‘251]iodosulphanilic acid. After labelling these nuclear and 
membrane fractions were washed in PBS. Cells were also disrupted and the whole cell extract labelled. The Ad 12 El 
proteins were immunoprecipitated using rat tumour bearer sera and run on 13Vo polyacrylamide gels. Scan a, 
immunoprecipitation of whole Ad 12 HEK2 cells labelled with [‘*‘I]iodosuIphanilic acid; scan b, immunoprecipitation 
of the membrane fraction from Ad 12 HEK2 cells labelled with iodosulphanilic acid before subcellular fractionation; 
scan c, immunoprecipitation of membrane fraction labelled with [‘251]iodosuIphanilic acid after subcellular 
fractionation; scan d, immunoprecipitation of a whole cell extract labelled after disruption. No labelled proteins were 
immunoprecipitated from the cytosolic fraction labelled before subcellular fractionation. No proteins were 
immunoprecipitated with non-immune rat serum. Similar results to those presented here were obtained when the 
experiment was repeated with Ad 12 EcoC HLBRK cells. 0 indicates the origin. 
233 
Volume 181, number 2 FEBS LETTERS February 1985 
protein was labelled in Ad 12-transformed cells. 
Since this protein is immunoprecipitated with 
tumour bearer serum of known specificity it must 
be encoded by Ad 12 El DNA but, at present, its 
relationship to the other, well characterised Ad 12 
Ela (41 kDa) and Elb (18 and 52 kDa) proteins is 
not clear. 
3.5. Surface labelling of Ad 12 Elb 18-kDa 
protein 
It was found for both the Ad 12-transformed 
human and rat cell lines (Ad 12 HEK2 and Ad 12 
Eco HLBRK) that the major iodinated protein, 
observed after surface labelling and im- 
munoprecipitation with tumour bearer sera, was 
the Ad 12 18-kDa Elb protein. This was detected 
in the whole cell extract and the membrane frac- 
tion but not in the cytosol (fig.2). When the mem- 
brane fraction was iodinated after fractionation 
rather more radioactivity was incorporated into 
the 18-kDa protein than when whole cells were 
treated (cf. fig.2, scans a-c). When the whole cell 
homogenates and the subcellular fractions were 
radiolabelled after fractionation the three Ad 12 
El proteins were iodinated (fig.2, scan d). It has 
been shown that most of the 52- and 41-kDa pro- 
teins are present in the cytoplasmic fraction with 
rather less in the nuclear fraction, and the majority 
of the 18-kDa protein in the membrane fraction 
v31. 
A number of workers have now shown that the 
smaller Elb protein of adenovirus (15 kDa in Ad 
2, 18-19 kDa in Ad 5 and 18 kDa in Ad 12) is 
mainly associated with a crude membrane fraction 
in transformed and infected cells [13,21,22]. The 
results presented here confirm this finding, 
although we have been able to detect only a single 
Elb component of about 18 kDa. This contrasts 
with the results of Rowe et al. [22] who found that 
after Ad 5 infection two related El b proteins of 
18.5 and 19 kDa were produced in equal amounts 
and both were membrane-bound. Reasons for this 
discrepancy are not clear although it might be in- 
dicative of group differences between Ad 12 and 
Ad 5. However, a number of workers [9,23] have 
demonstrated two Elb proteins of 17-19 kDa in 
Ad 12 in vitro translation studies. Here we have 
observed that on certain occasions after Ad 12 in- 
fection of HEKs a second minor band of about 
234 
15 kDa is labelled with [3H]palmitate (fig.1, scans 
k, 1). 
In the results presented here we have 
demonstrated for the first time that the Ad 12 
18 kDa protein has lipid covalently bound to it 
through an ester linkage. Although the function of 
acylation is not yet clear it is probable that it 
represents a post-translational modification re- 
quired to anchor the protein in the plasma mem- 
brane. The 18-kDa protein is not totally enclosed 
in the cell membrane, but extends through to the 
outside of the cells as shown by the iodination ex- 
periments in which only surface proteins are la- 
belled. As none of the other Ad 12 El proteins are 
detectable on the surface of transformed cells, or 
are even present within the membrane, it is 
reasonable to suppose that the 18-kDa protein is 
responsible for cell surface T-antigen activity in Ad 
1Ztransformed cells. This result confirms the find- 
ings of Fohring et al. [24] who came to a similar 
conclusion on the basis of a study of cytolytic T 
cell killing of a number of different Ad 
12-transformed rat cell lines. These workers found 
that the only Ad 12 El protein shared by all cell 
lines killed in cytolytic assays, is the 18-kDa Elb 
polypeptide. 
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